Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study

BACKGROUND: Triplet chemotherapy, with docetaxel-5FU-oxaliplatin (TEFOX), has yielded promising results in patients with advanced and operable gastric adenocarcinoma. This may prove useful in treating signet ring cell carcinoma (SRCC), which is known to be chemoresistant and has a poor prognosis. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Pernot, Simon, Dubreuil, Olivier, Aparicio, Thomas, Le Malicot, Karine, Tougeron, David, Lepère, Céline, Lecaille, Cedric, Marthey, Lysiane, Palle, Juliette, Bachet, Jean-Baptiste, Zaanan, Aziz, Taieb, Julien
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133962/
https://ncbi.nlm.nih.gov/pubmed/29872148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0133-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados